Search results for: rare disease

What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
ISPOR Europe 2023

We're thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We'll...

Read more
World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...

Read more
NICE’s Proportionate Approach to Technology ...

Webinar: Our experts discuss NICE's proportionate approach to technology appraisals and the implicat...

Read more
ISPOR Europe 2023: How Has NICE’s Severity M...

Our study aims to understand how the severity modifier has been implemented so far and its impact on...

Read more
Unlocking the Potential of Cell and Gene Therapy: ...

We outline the challenges pharma companies encounter when launching cell and gene therapies, and ass...

Read more
Orphan Medicine Market Access in Europe

Webinar: Our experts discuss Orphan medicine market access in Europe including the impact of EU HTA ...

Read more
Switzerland's 2024 Medicine Access Reforms

Switzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...

Read more
HUMN legislation – enabler or barrier for advanc...

This article explores the new EU pharmaceutical package and criteria of high unmet medical need (HUM...

Read more
Older
Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch